Samsung Bioepis Co., Ltd.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$335Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
95clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- E303 $32K associated (2023-2025)
- Sb5 $15K associated (2023-2025)
- E301 $11K associated (2023-2025)
- Sb12 $2,100 associated (2023-2025)
- Sb39 $2,000 associated (2023-2025)
- Sb15 $1,240 associated (2023-2025)
- Sb35 $700 associated (2023-2025)
- Sb16 $700 associated (2023-2025)
- Sb17 $500 associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Steven Feldman | Winston Salem, NC | Dermatology | $45,508.49 |
| Jonathan Kay | Worcester, MA | Rheumatology | $36,863.52 |
| Srinivas Sadda | Pasadena, CA | Ophthalmology | $29,585.55 |
| Gary Lyman | Seattle, WA | Medical Oncology | $20,677.10 |
| David Warrow | Hagerstown, MD | Ophthalmology | $13,421.42 |
| Terence Friedlander | San Francisco, CA | Hematology & Oncology | $9,425.35 |
| Mark Pegram | Stanford, CA | Medical Oncology | $8,778.95 |
| Peter Kaiser | Cleveland, OH | Ophthalmology | $7,600.00 |
| Vandana Abramson | Nashville, TN | Medical Oncology | $7,345.35 |
| Laurence Greenbaum | Atlanta, GA | Pediatric Nephrology | $7,328.00 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.